Product name

Cancer antigen 15-3 (CA 15-3)

Cancer antigen 19-9 (CA 19-9)

Cancer antigen 125 (CA 125)

Organ

Human liver metastases

Human ascites fluid

Human ascites fluid

Purity

Highly purified

Highly purified

> 95% (SDS-PAGE) 

State

Liquid

Liquid

Liquid

Activity

Typically > 500 kU/mL (Roche Elecsys EIA)

> 5,000 IU/mL (ELISA)

> 100 kU/mL (EIA)

Purity information

High purity, low cross-contamination with other cancer antigens

Low cross-contamination: CA-125, CEA, CA 19-9

Low cross-contamination: CA 15-3, CEA, CA 19-9

Purification

Gel filtration & ion-exchange chromatography

Composition

Solution in phosphate buffered saline, pH 7.4 with sucrose and 0.05% sodium azide

Solution in 1 M sodium chloride, 1% Triton™ X-100, 0.05% sodium azide, pH 7.4

Solution in phosphate buffered saline, pH 7.4 with 3% sucrose and 0.05% sodium azide

Appearance

Clear and colorless

Cloudy, light yellow solution

Storage

-20°C

-20°C

-20°C

Recertification

3 years

2 years

2 years

Testing for infectious diseases

Negative or non-reactive at the donor level for anti-HIV 1 and 2, anti-HCV and HBsAg by FDA approved methods

Negative or non-reactive at the donor level for anti-HIV 1 and 2, anti-HCV and HBsAg by FDA approved methods

Negative or non-reactive at the donor level for anti-HIV 1 and 2, anti-HCV and HBsAg by FDA approved methods

Synonyms

Tumour marker 19-9, CA 19-9, cancer antigen 19-9, carbohydrate antigen 19-9, sialyl Lewis (a) antigen

CA 15-3, tumour marker 15-3, mucin-1, MUC-1, breast carcinoma-associated antigen DF3, breast tumour antigen

MUCIN 16, muc16, CA-125, carbohydrate antigen 125, mucin-16